Magnetic antibody-linked nanomatchmakers for therapeutic cell targeting.
about
Remote magnetic targeting of iron oxide nanoparticles for cardiovascular diagnosis and therapeutic drug delivery: where are we now?Magnetic Nanoparticles for Targeting and Imaging of Stem Cells in Myocardial InfarctionNanoparticles-Assisted Stem Cell Therapy for Ischemic Heart DiseaseAdvanced cell therapies: targeting, tracking and actuation of cells with magnetic particlesNanoparticles for Cardiovascular Imaging and Therapeutic Delivery, Part 1: Compositions and FeaturesRole of P38 MAPK on MMP Activity in Photothrombotic Stroke Mice as Measured using an Ultrafast MMP Activatable Probe.Bio-imaging and Photodynamic Therapy with Tetra Sulphonatophenyl Porphyrin (TSPP)-TiO2 Nanowhiskers: New Approaches in Rheumatoid Arthritis TheranosticsMagnetic nanoparticles conjugated with "RPE cell -MCP-1 antibody -VEGF antibody" compounds for the targeted therapy of age-related macular degeneration: a hypothesisNanoscale strategies: treatment for peripheral vascular disease and critical limb ischemia.Magnetically Targeted Stem Cell Delivery for Regenerative Medicine.Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles.Bispecific antibodies, nanoparticles and cells: bringing the right cells to get the job done.Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues.The diagnostic value of iron oxide nanoparticles for imaging of myocardial inflammation--quo vadis?An effective strategy of magnetic stem cell delivery for spinal cord injury therapy.Tracking stem cells with superparamagnetic iron oxide nanoparticles: perspectives and considerations.A 3D magnetic tissue stretcher for remote mechanical control of embryonic stem cell differentiation.Fibrin-targeting delivery: a novel platform for cardiac regenerative medicine.Heart Repair Using Nanogel-Encapsulated Human Cardiac Stem Cells in Mice and Pigs with Myocardial Infarction.Multiscale technologies for treatment of ischemic cardiomyopathy.Recent Advances in the Generation of Antibody-Nanomaterial Conjugates.DNA-spheres decorated with magnetic nanocomposites based on terminal transfer reactions for versatile target detection and cellular targeted drug delivery.Constructing bifunctional nanoparticles for dual targeting: improved grafting and surface recognition assessment of multiple ligand nanoparticles.Recent Progress in Stem Cell Modification for Cardiac Regeneration.Concise Review: Is Cardiac Cell Therapy Dead? Embarrassing Trial Outcomes and New Directions for the Future.Nanoparticles for diagnosis and therapy of atherosclerosis and myocardial infarction: evolution toward prospective theranostic approachesExpanding the Boundaries of Biotherapeutics with Bispecific Antibodies
P2860
Q26739877-DCA7F2D1-8DFD-4598-986A-F85CAE7CB833Q26749032-8E1BEA0D-6C9F-435F-9B00-A019AE8D63ABQ26770129-DD7C1A20-0C5C-406C-A575-4B6D280D80B0Q26782710-6210806A-0453-4102-AEE7-97B5FCBFF151Q26798426-99EAA672-8FB8-49AC-B72A-824F559A4128Q27305326-ED2E9B70-8FDF-4803-87D6-D64C6C9816E5Q27308865-41D4C6F3-D378-49D0-A578-09483D8FCD5EQ33706139-3CE19849-884A-453B-942B-7B29BF7E2DF4Q33864915-2719CA4D-E296-4A09-A118-AEC0305A5184Q36138808-DE153187-D811-447F-A854-083D1CB74530Q36408240-9A45DD12-6878-4643-9544-F55147775839Q36600044-70B0F35C-E3BC-4CA8-ABDE-3C09E1F37E1CQ37543916-589F5355-3058-410F-9465-355F54ABC6E4Q38543648-FD1E41CD-57A1-414F-BB3B-9000E30602D5Q39043032-0D50A3ED-F1DA-4AB4-A3FC-EE717B40F56CQ39128194-38942585-ECD9-45E2-B7C7-3BD05A74AA1CQ41193224-411D63CF-0579-464C-94BE-B9F0A537253CQ42359748-F9A20B21-7D2A-414F-A687-B455478381C4Q42628519-5C5E66DB-C19B-46E8-9F85-866683B0ACBFQ46454164-243D1F1F-F9CC-4DCC-9B3E-41311E2C4F6CQ47725919-C4F68229-D1CF-428E-9939-D3A1D371B574Q50912521-3BC8B718-8CB7-48BC-ABBD-56E1DECF73DDQ51421044-7B5335EF-2B10-4682-94AA-58E3B98BAE20Q52657125-A39EBC4B-3E5F-4B77-8A28-E4846491B407Q52690932-683B61B8-EC8B-421E-B8D9-EC4CBBD25AB9Q57116116-61D7C304-95C8-4654-A1FD-60EDEE15CD9BQ58724935-3D595CCA-B684-447C-AF37-0DE6B87AF452
P2860
Magnetic antibody-linked nanomatchmakers for therapeutic cell targeting.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Magnetic antibody-linked nanomatchmakers for therapeutic cell targeting.
@ast
Magnetic antibody-linked nanomatchmakers for therapeutic cell targeting.
@en
Magnetic antibody-linked nanomatchmakers for therapeutic cell targeting.
@nl
type
label
Magnetic antibody-linked nanomatchmakers for therapeutic cell targeting.
@ast
Magnetic antibody-linked nanomatchmakers for therapeutic cell targeting.
@en
Magnetic antibody-linked nanomatchmakers for therapeutic cell targeting.
@nl
prefLabel
Magnetic antibody-linked nanomatchmakers for therapeutic cell targeting.
@ast
Magnetic antibody-linked nanomatchmakers for therapeutic cell targeting.
@en
Magnetic antibody-linked nanomatchmakers for therapeutic cell targeting.
@nl
P2093
P2860
P356
P1476
Magnetic antibody-linked nanomatchmakers for therapeutic cell targeting.
@en
P2093
Baiming Sun
Deliang Shen
Eduardo Marbán
Geoffrey De Couto
M Taylor Hensley
Ryan Middleton
Weixin Liu
P2860
P2888
P356
10.1038/NCOMMS5880
P577
2014-09-10T00:00:00Z
P5875
P6179
1003722616